77 related articles for article (PubMed ID: 11115396)
1. Probing mucin-type O-linked glycosylation in living animals.
Dube DH; Prescher JA; Quang CN; Bertozzi CR
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4819-24. PubMed ID: 16549800
[TBL] [Abstract][Full Text] [Related]
2. Supported Molecular Matrix Electrophoresis.
Kameyama A
Methods Mol Biol; 2024; 2763():79-97. PubMed ID: 38347402
[TBL] [Abstract][Full Text] [Related]
3. MUC21: a new target for tumor treatment.
Li M; Li H; Yuan T; Liu Z; Li Y; Tan Y; Long Y
Front Oncol; 2024; 14():1410761. PubMed ID: 38933439
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model.
Sungsuwan S; Wu X; Huang X
Methods Enzymol; 2017; 597():359-376. PubMed ID: 28935111
[TBL] [Abstract][Full Text] [Related]
5. Altered Mucins (MUC) trafficking in benign and malignant conditions.
Joshi S; Kumar S; Choudhury A; Ponnusamy MP; Batra SK
Oncotarget; 2014 Sep; 5(17):7272-84. PubMed ID: 25261375
[TBL] [Abstract][Full Text] [Related]
6. Mucins in the mucosal barrier to infection.
Linden SK; Sutton P; Karlsson NG; Korolik V; McGuckin MA
Mucosal Immunol; 2008 May; 1(3):183-97. PubMed ID: 19079178
[TBL] [Abstract][Full Text] [Related]
7. Mucins and blastocyst attachment.
Thathiah A; Carson DD
Rev Endocr Metab Disord; 2002 May; 3(2):87-96. PubMed ID: 12007285
[No Abstract] [Full Text] [Related]
8. Carcinoma associated mucins: molecular biology and clinical applications.
Verma M
Cancer Biochem Biophys; 1994 Oct; 14(3):151-62. PubMed ID: 7728736
[TBL] [Abstract][Full Text] [Related]
9. Novel bifidobacterial glycosidases acting on sugar chains of mucin glycoproteins.
Katayama T; Fujita K; Yamamoto K
J Biosci Bioeng; 2005 May; 99(5):457-65. PubMed ID: 16233817
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis and shedding of epiglycanin: a mucin-type glycoprotein of the mouse TA3Ha mammary carcinoma cell.
Thingstad T; Vos HL; Hilkens J
Biochem J; 2001 Jan; 353(Pt 1):33-40. PubMed ID: 11115396
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis pathway of gp90MEL-14, the mouse lymph node-specific homing receptor.
van de Rijn M; Weissman IL; Siegelman M
J Immunol; 1990 Sep; 145(5):1477-82. PubMed ID: 2166761
[TBL] [Abstract][Full Text] [Related]
12. N-glycosylation is required for the surface localization of MUC17 mucin.
Ho JJ; Jaituni RS; Crawley SC; Yang SC; Gum JR; Kim YS
Int J Oncol; 2003 Sep; 23(3):585-92. PubMed ID: 12888891
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP
J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577
[TBL] [Abstract][Full Text] [Related]
14. Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin.
Itoh Y; Kamata-Sakurai M; Denda-Nagai K; Nagai S; Tsuiji M; Ishii-Schrade K; Okada K; Goto A; Fukayama M; Irimura T
Glycobiology; 2008 Jan; 18(1):74-83. PubMed ID: 17977904
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
